rs34046352

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001018115.3(FANCD2):ā€‹c.1122A>Gā€‹(p.Val374Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.193 in 151,510 control chromosomes in the GnomAD database, including 236 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.19 ( 236 hom., cov: 34)
Exomes š‘“: 0.10 ( 155 hom. )
Failed GnomAD Quality Control

Consequence

FANCD2
NM_001018115.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0460
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 3-10043852-A-G is Benign according to our data. Variant chr3-10043852-A-G is described in ClinVar as [Benign]. Clinvar id is 257065.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-10043852-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.046 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FANCD2NM_001018115.3 linkuse as main transcriptc.1122A>G p.Val374Val synonymous_variant 14/44 ENST00000675286.1 NP_001018125.1 Q9BXW9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FANCD2ENST00000675286.1 linkuse as main transcriptc.1122A>G p.Val374Val synonymous_variant 14/44 NM_001018115.3 ENSP00000502379.1 Q9BXW9-2

Frequencies

GnomAD3 genomes
AF:
0.193
AC:
29209
AN:
151394
Hom.:
235
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.335
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.141
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.0604
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.108
Gnomad MID
AF:
0.121
Gnomad NFE
AF:
0.148
Gnomad OTH
AF:
0.171
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0998
AC:
128878
AN:
1291182
Hom.:
155
Cov.:
31
AF XY:
0.102
AC XY:
65695
AN XY:
645390
show subpopulations
Gnomad4 AFR exome
AF:
0.300
Gnomad4 AMR exome
AF:
0.123
Gnomad4 ASJ exome
AF:
0.117
Gnomad4 EAS exome
AF:
0.0471
Gnomad4 SAS exome
AF:
0.131
Gnomad4 FIN exome
AF:
0.107
Gnomad4 NFE exome
AF:
0.0906
Gnomad4 OTH exome
AF:
0.117
GnomAD4 genome
AF:
0.193
AC:
29240
AN:
151510
Hom.:
236
Cov.:
34
AF XY:
0.188
AC XY:
13895
AN XY:
74088
show subpopulations
Gnomad4 AFR
AF:
0.335
Gnomad4 AMR
AF:
0.141
Gnomad4 ASJ
AF:
0.142
Gnomad4 EAS
AF:
0.0603
Gnomad4 SAS
AF:
0.148
Gnomad4 FIN
AF:
0.108
Gnomad4 NFE
AF:
0.148
Gnomad4 OTH
AF:
0.170
Alfa
AF:
0.170
Hom.:
29

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJun 12, 2020- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 10, 2016- -
Fanconi anemia complementation group D2 Benign:2
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 11, 2019- -
Fanconi anemia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Fanconi anemia complementation group A Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Hereditary breast ovarian cancer syndrome Benign:1
Benign, criteria provided, single submitterclinical testingNational Health Laboratory Service, Universitas Academic Hospital and University of the Free StateApr 19, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.2
DANN
Benign
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34046352; hg19: chr3-10085536; COSMIC: COSV55037937; COSMIC: COSV55037937; API